Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population.

Carmen Gruzei; Jufen Zhang; Rupert Bourne

doi:10.1007/s10792-021-02044-0

Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population.

Carmen Gruzei, Jufen Zhang, Rupert Bourne

Research output: Contribution to journal › Original Article › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	785-797
Journal	INTERNATIONAL OPHTHALMOLOGY
Volume	42
Issue number	3
DOIs	https://doi.org/10.1007/s10792-021-02044-0
Publication status	Published - 2022

Keywords

VISUAL-FIELD PROGRESSION
INTRAOCULAR-PRESSURE REDUCTION
RISK-FACTORS
RATES
PREVALENCE
DESIGN

Access to Document

10.1007/s10792-021-02044-0

Cite this

@article{6ac1deabdf9943f39e37bcd33a56c659,

title = "Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population.",

keywords = "VISUAL-FIELD PROGRESSION, INTRAOCULAR-PRESSURE REDUCTION, RISK-FACTORS, RATES, PREVALENCE, DESIGN",

author = "Carmen Gruzei and Jufen Zhang and Rupert Bourne",

note = "Gruzei: Paracelsus Medical University, Salzburg, Austria.",

year = "2022",

doi = "10.1007/s10792-021-02044-0",

language = "English",

volume = "42",

pages = "785--797",

journal = "INTERNATIONAL OPHTHALMOLOGY",

issn = "0165-5701",

number = "3",

}

TY - JOUR

T1 - Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population.

AU - Gruzei, Carmen

AU - Zhang, Jufen

AU - Bourne, Rupert

N1 - Gruzei: Paracelsus Medical University, Salzburg, Austria.

PY - 2022

Y1 - 2022

KW - VISUAL-FIELD PROGRESSION

KW - INTRAOCULAR-PRESSURE REDUCTION

KW - RISK-FACTORS

KW - RATES

KW - PREVALENCE

KW - DESIGN

U2 - 10.1007/s10792-021-02044-0

DO - 10.1007/s10792-021-02044-0

M3 - Original Article

C2 - 34989952

SN - 0165-5701

VL - 42

SP - 785

EP - 797

JO - INTERNATIONAL OPHTHALMOLOGY

JF - INTERNATIONAL OPHTHALMOLOGY

IS - 3

ER -